| 1 | BRAZIKUMAB | 1件:  Brazikumab Brazikumab | 1件:  D10912 
                
                    D10912
                
             (Name: Brazikumab) | 1件:  IL23A IL23A 💬 | 9件:  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件:  96 96, 97 | 
| 2 | Brazikumab high dose | 1件:  Brazikumab Brazikumab | 1件:  D10912 
                
                    D10912
                
             (Name: Brazikumab) | 1件:  IL23A IL23A 💬 | 9件:  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件:  96 96 | 
| 3 | Brazikumab Induction Dose | 1件:  Brazikumab Brazikumab | 1件:  D10912 
                
                    D10912
                
             (Name: Brazikumab) | 1件:  IL23A IL23A 💬 | 9件:  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件:  96 96, 97 | 
| 4 | Brazikumab IV Infusion | 1件:  Brazikumab Brazikumab | 1件:  D10912 
                
                    D10912
                
             (Name: Brazikumab) | 1件:  IL23A IL23A 💬 | 9件:  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件:  96 96 | 
| 5 | Brazikumab low dose | 1件:  Brazikumab Brazikumab | 1件:  D10912 
                
                    D10912
                
             (Name: Brazikumab) | 1件:  IL23A IL23A 💬 | 9件:  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件:  96 96 | 
| 6 | Brazikumab Maintenance Dose | 1件:  Brazikumab Brazikumab | 1件:  D10912 
                
                    D10912
                
             (Name: Brazikumab) | 1件:  IL23A IL23A 💬 | 9件:  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件:  96 96, 97 | 
| 7 | Brazikumab SC Injection | 1件:  Brazikumab Brazikumab | 1件:  D10912 
                
                    D10912
                
             (Name: Brazikumab) | 1件:  IL23A IL23A 💬 | 9件:  C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件:  96 96 |